| Name | tert-butyl 4-(2-chloro-4-methoxycarbonylphenyl)piperazine-1-carboxylate |
|---|---|
| Synonyms |
Methyl 4-(4-Boc-1-piperazinyl)-3-chlorobenzoate
4-[2-Chloro-4-(methoxycarbonyl)phenyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester |
| Density | 1.224±0.06 g/cm3 |
|---|---|
| Molecular Formula | C17H23ClN2O4 |
| Molecular Weight | 354.82900 |
| Exact Mass | 354.13500 |
| PSA | 59.08000 |
| LogP | 3.18660 |
| Water Solubility | Very slightly soluble (0.24 g/L) (25 ºC) |
| HS Code | 2933599090 |
|---|
|
~%
906559-46-4 |
| Literature: WO2006/88919 A2, ; Page/Page column 142-143 ; WO 2006/088919 A2 |
|
~%
906559-46-4 |
| Literature: SCHERING CORPORATION; PHARMACOPEIA DRUG DISCOVERY, INC. Patent: WO2006/88919 A2, 2006 ; Location in patent: Page/Page column 142-143 ; WO 2006/088919 A2 |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |